Abstract
Multiple myeloma (MM) is frequently diagnosed among elderly, who are not commonly considered eligible to the autologous stem cell transplantation (ASCT). This observational retrospective analysis aimed to describe, from the perspective of the Italian National Health Service (INHS), newly MM diagnosed subjects, their direct healthcare costs and rate of ASCT, from 2015 to 2019.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
